Advanced Proteome Appoints Dr. Randal Chase to Its Board
June 02, 2015 09:00 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - June 02, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce the appointment of Dr....
Advanced Proteome Therapeutics Reports on Warrant Exercise
May 19, 2015 09:15 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - May 19, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to report that all of the 3,100,000...
Advanced Proteome Therapeutics' Lead Compound Inhibits Metastasis in Breast Cancer Tumor Model
April 29, 2015 12:47 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - April 29, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its current lead...
Advanced Proteome Therapeutics Reports Successful Fusion Protein Initiative Resulting in APC 103 Which Retards Tumor Growth in an Animal Model
April 27, 2015 09:00 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - April 27, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its new fusion...
Advanced Proteome Therapeutics Corporation Announces Issuance of a New U.S. Patent for Modifying Proteins to Enhance Their Biological Activities
April 13, 2015 09:15 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - April 13, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) wishes to announce that the U.S. Patent and...
Advanced Proteome Therapeutics Provides Corporate Update on Multiple Activities
March 23, 2015 12:46 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - March 23, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to provide the following corporate...
In an Exclusive Interview the CEO of Advanced Proteome Therapeutics (APC) Discusses the Company's Technology and R&D Strategy
January 29, 2015 11:19 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - January 29, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) announces that APC was profiled in a...
Advanced Proteome Therapeutics Engages CRO to Escalate Testing of Promising Cancer Therapy
November 12, 2014 13:33 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - November 12, 2014) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) is pleased to announce that it has entered...
APC Announces Positive Results in Combination Cancer Immunotherapy
September 11, 2014 09:00 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - September 11, 2014) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is excited to report results from its...
Advanced Proteome Therapeutics Expands Anticancer Studies Based on Strong Initial Results
August 12, 2014 09:27 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 12, 2014) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to announce...